A.5 RADIOTERAPIA

Antonio Gómez, CHUS

Contenido Mostrar índice de contenidos

A.5. RADIOTERAPIA

A.5.1. RADIOTERAPIA RADICAL

  • Branislav Jeremic, Johannes Classen, Michael Bamberg. Radiotherapy alone in technically operable, medically inoperable, early-stage (I/II) non-small-cell lung cancer International Journal of Radiation Oncology * Biology * Physics Vol. 54, Issue 1, Pages 119-130
  • Rowell NP, Williams CJ. Radical radiotherapy for stage I/II non-small cell lung cancer in patients not sufficiently fit for or declining surgery (medically inoperable). Cochrane Database Syst Rev 2001.

A.5.2. RADIOTERAPIA PALIATIVA

  • Falk SJ, Girling DJ, White RJ, et al. Immediate versus delayed palliative thoracic radiotherapy in patients with unresectable locally advanced non-small cell lung cancer and minimal thoracic symptoms: randomised controlled trial. BMJ 2002; 325:465.

A.5.3. RADIOTERAPIA POSTOPERATORIA

  • PORT Meta-analysis Trialists Group: Post-operative radiotherapy in non-small cell lung cancer: Systematic review and meta-analysis of individual patient data from nine randomised controlled trials. Lancet 352:257-263, 1998.
  • Burdett S, Stewart L: Postoperative radiotherapy in non small cell lung cancer: Up date of an individual patient data meta-analysis. Lung Cancer 47:81-83, 2005.
  • Machtay M, Lee JH, Shrager JB, et al: Risk of death from intercurrent disease is not excessively increased by modern postoperative radiotherapy for high-risk resected non-small-cell lung carcinoma. J Clin Oncol 19:3912-3917, 2001.
  • Lally BE, Zelterman D, Colasanto JM, Haffty BG, Detterbeck FC, Wilson LD. Postoperative radiotherapy for stage II or III non-small-cell lung cancer using the surveillance, epidemiology, and end results database. J Clin Oncol 24:2998–3006, 2006.
  • Keller SM, Adak S, Wagner H, et al: A randomized trial of post-operative adjuvant therapy in patients with completely resected stage II or III-A non-small cell lung cancer: Eastern Cooperative Oncology Group. N Engl J Med 343:1217-1222, 2000.
  • Bonner JA, Spencer SA: Postoperative radiotherapy in non-small-cell lung cancer warrants further exploration in the era of adjuvant chemotherapy and conformal radiotherapy. J Clin Oncol 24:2978-2980, 2006.
  • Douillard JY, Rosell R, De Lena M, Riggi M, Hurteloup P, Mahe MA; Adjuvant Navelbine International Trialist Association. Impact of postoperative radiation therapy on survival in patients with complete resection and stage I, II, or IIIA non-small-cell lung cancer treated with adjuvant chemotherapy: the adjuvant Navelbine International Trialist Association (ANITA) Randomized Trial. Int J Radiat Oncol Biol Phys. 72:695-701, 2008.

A.5.4. SBRT

  • Potters L, Kavanagh B, Galvin JM, et al. American Society for Therapeutic Radiology and Oncology (ASTRO) and American College of Radiology (ACR) practice guideline for the performance of stereotactic body radiation therapy. Int J Radiat Oncol Biol Phys 2010; 76:326.
  • Timmerman R, Paulus R, Galvin J, et al. Stereotactic body radiation therapy for inoperable early stage lung cancer. JAMA 2010; 303:1070.
  • Palma D, Visser O, Lagerwaard FJ, et al. Impact of introducing stereotactic lung radiotherapy for elderly patients with stage I non-small-cell lung cancer: a population-based time-trend analysis. J Clin Oncol 2010; 28:5153.
  • Alexander V. Louie, George Rodrigues, Malek Hannouf, Gregory S. Zaric, et al. Stereotactic Body Radiotherapy Versus Surgery for Medically Operable Stage I Non–Small-Cell Lung Cancer: A Markov Model–Based Decision Analysis. International Journal of Radiation Oncology * Biology * Physics Vol. 81, Issue 4, Pages 964-973
  • Mark K. Buyyounouski, Peter Balter, Brett Lewis, David J. D’Ambrosio, et al. Stereotactic Body Radiotherapy for Early-Stage Non-Small-Cell Lung Cancer: Report of the ASTRO Emerging Technology Committee. International Journal of Radiation Oncology * Biology * Physics Vol. 78, Issue 1, Pages 3-10
  • David Palma, Frank Lagerwaard, George Rodrigues, Cornelis Haasbeek, et al.Curative Treatment of Stage I Non-Small-Cell Lung Cancer in Patients With Severe COPD: Stereotactic Radiotherapy Outcomes and Systematic Review. International Journal of Radiation Oncology * Biology * Physics Vol. 82, Issue 3, Pages 1149-1156
  • Hiroshi Onishi, Hiroki Shirato, Yasushi Nagata, Masahiro Hiraoka, et al. Stereotactic Body Radiotherapy (SBRT) for Operable Stage I Non–Small-Cell Lung Cancer: Can SBRT Be Comparable to Surgery. International Journal of Radiation Oncology * Biology * Physics Vol. 81, Issue 5, Pages 1352-1358
  • Patrick Kelly, Peter A. Balter, Neal Rebueno, Hadley J. Sharp, et al. Stereotactic Body Radiation Therapy for Patients With Lung Cancer Previously Treated With Thoracic Radiation. International Journal of Radiation Oncology * Biology * Physics Vol. 78, Issue 5, Pages 1387-1393
  • Alexander Chi, Zhongxing Liao, Nam P. Nguyen, Jiahong Xu, et al. Systemic review of the patterns of failure following stereotactic body radiation therapy in early-stage non-small-cell lung cancer: Clinical implications. Radiotherapy and Oncology Vol. 94, Issue 1, Pages 1-11

A.5.5. HIPERFRACCIONAMIENTO

  • Saunders M, Dische S, Barrett A, et al. Continuous, hyperfractionated, accelerated radiotherapy (CHART) versus conventional radiotherapy in non-small cell lung cancer: mature data from the randomised multicentre trial. CHART Steering committee. Radiother Oncol 1999; 52:137.
  • Branislav Jeremić, Biljana Miličić, Slobodan Milisavljevic. Concurrent Hyperfractionated Radiation Therapy and Chemotherapy in Locally Advanced (Stage III) Non-Small-Cell Lung Cancer: Single Institution Experience With 600 Patients. International Journal of Radiation Oncology * Biology * Physics Vol. 82, Issue 3, Pages 1157-1163
  • Matthew Hatton, Matthew Nankivell, Ethan Lyn, Stephen Falk, et al. Induction Chemotherapy and Continuous Hyperfractionated Accelerated Radiotherapy (CHART) for Patients With Locally Advanced Inoperable Non–Small-Cell Lung Cancer: The MRC INCH Randomized Trial .International Journal of Radiation Oncology * Biology * Physics Vol. 81, Issue 3, Pages 712-718
  • M. Baumann, T. Herrmann, R. Koch, W. Matthiessen, et al. Final results of the randomized phase III CHARTWEL-trial (ARO 97-1) comparing hyperfractionated-accelerated versus conventionally fractionated radiotherapy in non-small cell Lung Cancer (NSCLC). Radiotherapy and Oncology Vol. 100, Issue 1, Pages 76-85
  • Jeremić B, Milicić B. From conventionally fractionated radiation therapy to hyperfractionated radiation therapy alone and with concurrent chemotherapy in patients with early-stage nonsmall cell lung cancer. Cancer 2008; 112:876.

A.5.6. Irradiación profiláctica craneal

  • Aupérin A., Arriagada R., Pignon J.-P., et al.Prophylactic Cranial Irradiation for Patients with Small-Cell Lung Cancer in Complete Remission.N Engl J Med 1999; 341:476 – 484
  • Slotman B., Faivre-Finn C., Kramer G., et al. Prophylactic Cranial Irradiation in Extensive Small-Cell Lung Cancer. N Engl J Med 2007; 357:664 – 672
  • Aaron H. Wolfson, Kyounghwa Bae, Ritsuko Komaki, Christina Meyers, et al. Primary Analysis of a Phase II Randomized Trial Radiation Therapy Oncology Group (RTOG) 0212: Impact of Different Total Doses and Schedules of Prophylactic Cranial Irradiation on Chronic Neurotoxicity and Quality of Life for Patients With Limited-Disease Small-Cell Lung Cancer .International Journal of Radiation Oncology * Biology * Physics Vol. 81, Issue 1, Pages 77-84
  • Le Péchoux C, Dunant A, Senan S, et al. Standard-dose versus higher-dose prophylactic cranial irradiation (PCI) in patients with limited-stage small-cell lung cancer in complete remission after chemotherapy and thoracic radiotherapy (PCI 99-01, EORTC 22003-08004, RTOG 0212, and IFCT 99-01): a randomised clinical trial. Lancet Oncol 2009; 10:467.
  • Meert AP, Paesmans M, Berghmans T, et al. Prophylactic cranial irradiation in small cell lung cancer: a systematic review of the literature with meta-analysis. BMC Cancer 2001; 1:5.
  • Lester JF, MacBeth FR, Coles B. Prophylactic cranial irradiation for preventing brain metastases in patients undergoing radical treatment for non-small-cell lung cancer: a Cochrane Review. Int J Radiat Oncol Biol Phys 2005; 63:690.
  • Gore EM, Bae K, Wong SJ, et al. Phase III comparison of prophylactic cranial irradiation versus observation in patients with locally advanced non-small-cell lung cancer: primary analysis of radiation therapy oncology group study RTOG 0214. J Clin Oncol 2011; 29:272.
  • Sun A, Bae K, Gore EM, et al. Phase III trial of prophylactic cranial irradiation compared with observation in patients with locally advanced non-small-cell lung cancer: neurocognitive and quality-of-life analysis. J Clin Oncol 2011; 29:279.

A.5.7. IRRADIACION NODAL

  • José S.A. Belderbos, Lucyna Kepka, Feng-Ming (Spring) Kong, Mary K. Martel, et al. Report From the International Atomic Energy Agency (IAEA) Consultants’ Meeting on Elective Nodal Irradiation in Lung Cancer : Non–Small-Cell Lung Cancer (NSCLC). International Journal of Radiation Oncology * Biology * Physics Vol. 72, Issue 2, Pages 335-342
  • Gregory M.M. Videtic, José S.A. Belderbos, Feng-Ming (Spring) Kong, Lucyna Kepka, et al. Report From the International Atomic Energy Agency (IAEA) Consultants’ Meeting on Elective Nodal Irradiation in Lung Cancer : Small-Cell Lung Cancer (SCLC). International Journal of Radiation Oncology * Biology * Physics Vol. 72, Issue 2, Pages 327-334
  • Judith van Loon, Dirk De Ruysscher, Rinus Wanders, Liesbeth Boersma, et al. Selective Nodal Irradiation on Basis of 18FDG-PET Scans in Limited-Disease Small-Cell Lung Cancer: A Prospective Study. International Journal of Radiation Oncology * Biology * Physics Vol. 77, Issue 2, Pages 329-336
  • Annemarie T. Fernandes, Jason Shen, Jarod Finlay, Nandita Mitra, et al. Elective nodal irradiation (ENI) vs. involved field radiotherapy (IFRT) for locally advanced non-small cell lung cancer(NSCLC): A comparative analysis of toxicities and clinical outcomes. Radiotherapy and Oncology Vol. 95, Issue 2, Pages 178-184

A.5.8. TOXICIDAD

  • Vivek Mehta .Radiation pneumonitis and pulmonary fibrosis in non–small-cell lung cancer: Pulmonary function, prediction, and prevention. International Journal of Radiation Oncology * Biology * Physics Vol. 63, Issue 1, Pages 5-24
  • Shulian Wang, Zhongxing Liao, Xiong Wei, Helen H. Liu, et al. Analysis of clinical and dosimetric factors associated with treatment-related pneumonitis (TRP) in patients with non–small-cell lung cancer (NSCLC) treated with concurrent chemotherapy and three-dimensional conformal radiotherapy (3D-CRT). International Journal of Radiation Oncology * Biology * Physics Vol. 66, Issue 5, Pages 1399-1407
  • George Rodrigues, Michael Lock, David D’Souza, Edward Yu, et al.Prediction of radiation pneumonitis by dose–volume histogram parameters in lung cancer—a systematic review. Radiotherapy and Oncology Vol. 71, Issue 2, Pages 127-138.

A.5.9. TECNOLOGIA

  • Hilke Vorwerk, Gabriele Beckmann, Michael Bremer, Maria Degen, et al. The delineation of target volumes for radiotherapy of lung cancer patients. Radiotherapy and Oncology Vol. 91, Issue 3, Pages 455-460
  • Ursula Nestle, Stephanie Kremp, Anca-Ligia Grosu. Practical integration of [18F]-FDG-PET and PET-CT in the planning of radiotherapy for non-small cell lung cancer (NSCLC): The technical basis, ICRU-target volumes, problems, perspectives. Radiotherapy and Oncology Vol. 81, Issue 2, Pages 209-225
  • Janneke P.C. Grutters, Alfons G.H. Kessels, Madelon Pijls-Johannesma, Dirk De Ruysscher, et al. Comparison of the effectiveness of radiotherapy with photons, protons and carbon-ions for non-small cell lung cancer: A meta-analysis. Radiotherapy and Oncology Vol. 95, Issue 1, Pages 32-40
  • Zhongxing X. Liao, Ritsuko R. Komaki, Howard D. Thames, Helen H. Liu, et al. Influence of Technologic Advances on Outcomes in Patients With Unresectable, Locally Advanced Non–Small-Cell Lung Cancer Receiving Concomitant Chemoradiotherapy. International Journal of Radiation Oncology * Biology * Physics Vol. 76, Issue 3, Pages 775-781
  • Suresh Senan, Dirk De Ruysscher, Philippe Giraud, René Mirimanoff, et al. Literature-based recommendations for treatment planning and execution in high-dose radiotherapy for lung cancer. Radiotherapy and Oncology Vol. 71, Issue 2, Pages 139-146
  • Lamberto Widesott, Maurizio Amichetti, Marco Schwarz. Proton therapy in lung cancer: Clinical outcomes and technical issues. A systematic review. Radiotherapy and Oncology Vol. 86, Issue 2, Pages 154-164

A.5.10. MISCELANEA

  • Jacek Jassem. The role of radiotherapy in lung cancer: Where is the evidence? Radiotherapy and Oncology Vol. 83, Issue 2, Pages 203-213
  • N.A. Bayman, H. Sheikh, B. Kularatne, P. Lorigan, F. Blackhall, N. Thatcher, C. Faivre-Finn. Radiotherapy for small-cell lung cancer—Where are we heading? Lung Cancer, Volume 63, Issue 3, March 2009, Pages 307-314
  • Ben J. Slotman, Suresh Senan. Radiotherapy in Small-Cell Lung Cancer: Lessons Learned and Future Directions. International Journal of Radiation Oncology * Biology * Physics Vol. 79, Issue 4, Pages 998-1003
  • Neil Bayman, Nooreen Alam, Corinne Faivre-Finn. Radiotherapy for lung cancer in the elderly. Lung Cancer, Volume 68, Issue 2, May 2010, Pages 129-136
  • David Raben, Barb Helfrich, Paul A Bunn. Targeted therapies for non–small-cell lung cancer: biology, rationale, and preclinical results from a radiation oncology perspective. International Journal of Radiation Oncology * Biology * Physics Vol. 59, Issue 2, Supplement, Pages S27-S38
  • Branislav Jeremić, Gregory M.M. Videtic. Chest Reirradiation With External Beam Radiotherapy for Locally Recurrent Non-Small-Cell Lung Cancer: A Review. International Journal of Radiation Oncology * Biology * Physics Vol. 80, Issue 4, Pages 969-977
  • Dirk De Ruysscher, Cary Dehing, Søren M. Bentzen, Ruud Houben, et al. Can we optimize chemo-radiation and surgery in locally advanced stage III non-small cell lung cancer based on evidence from randomized clinical trials? A hypothesis-generating study. Radiotherapy and Oncology Vol. 93, Issue 3, Pages 389-395
  • Delaney G, Barton M, Jacob S, Jalaludin B. A model for decision making for the use of radiotherapy in lung cancer. Lancet Oncol. 2003 Feb;4(2):120-8.